Retatrutide Shows Promising Weight Loss and Osteoarthritis Pain Relief in Phase 3 Trial | Retatrutide News

Eli Lilly's retatrutide achieved significant weight loss and osteoarthritis pain relief in a Phase 3 trial. This underscores the potential of GLP-1 agon...
Clinical Trials · October 25, 2026